beta-D-Xylp-(1->4)-alpha-L-Arap-(1->6)-beta-D-Glcp

Term ID

CHEBI:146704

Synonyms

(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
beta-D-xylo-pentopyranosyl-(1->4)-alpha-L-arabino-pentopyranosyl-(1->6)-beta-D-gluco-hexopyranose
beta-D-xylopyranosyl-(1->4)-alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranose
WURCS=2.0/3,3,2/[a2122h-1b_1-5][a211h-1a_1-5][a212h-1b_1-5]/1-2-3/a6-b1_b4-c1
Xyl(b1-4)Ara(a1-6)b-Glc

(all 5)

Definition

A trisaccharide consisting of beta-D-xylopyranose, alpha-L-arabinopyranose and beta-D-glucopyranose joined in sequence by (1->4) and (1->6) glycosidic linkages.

References

GlyTouCan:G04295FF

Ontology

ChEBI ( EBI )

Relationships

is a type of: trisaccharide

trisaccharide Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Xylp-(1->4)-alpha-L-Arap-(1->6)-beta-D-Glcp

Phenotype where environments contain beta-D-Xylp-(1->4)-alpha-L-Arap-(1->6)-beta-D-Glcp

Phenotype modified by environments containing beta-D-Xylp-(1->4)-alpha-L-Arap-(1->6)-beta-D-Glcp

Phenotype affecting beta-D-Xylp-(1->4)-alpha-L-Arap-(1->6)-beta-D-Glcp

Human Disease Model